Literature DB >> 16315133

Pathology of hepatic iron overload.

Elizabeth M Brunt1.   

Abstract

The role of liver biopsy in all chronic liver diseases continues to evolve with the emergence of new laboratory and imaging tests. However, the value of histologic examination for fibrosis, parenchymal architectural remodeling, and possible concurrent disease remains relatively unchallenged, including in patients with suspected iron overload. In addition, only histologic evaluation allows detailed analysis of cellular and acinar localization of iron. Routine use of an iron stain for all liver biopsy analysis enables detection of iron when not otherwise suspected. The broad classifications of iron overload include parenchymal ("primary") or reticuloendothelial ("secondary"), and mixed. These classifications, however, serve only as guidelines to differential diagnoses, as will be noted in the following review of pathology of iron overload. Ultimately, the role of the pathologist is to document cellular and acinar localization of iron and to provide a semiquantitative assessment of amount to alert the clinician to the possibility of a significant condition. In this article, histopathologic findings in conditions of iron overload and in several forms of liver disease are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16315133     DOI: 10.1055/s-2005-923311

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  12 in total

1.  Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease.

Authors:  James E Nelson; Laura Wilson; Elizabeth M Brunt; Matthew M Yeh; David E Kleiner; Aynur Unalp-Arida; Kris V Kowdley
Journal:  Hepatology       Date:  2010-11-29       Impact factor: 17.425

Review 2.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

3.  Iron metabolic disorder in chronic hepatitis C: insights from recent evidence.

Authors:  Keisuke Hino; Sohji Nishina; Yuichi Hara
Journal:  Clin J Gastroenterol       Date:  2012-07-31

Review 4.  Iron metabolism in Nonalcoholic Fatty Liver Disease.

Authors:  James E Nelson; Heather Klintworth; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2012-02

5.  Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.

Authors:  Dustin E Bosch; Yoh Zen; Sarag A Boukhar; Yongjun Liu; Lin Cheng; Matthew M Yeh
Journal:  Virchows Arch       Date:  2021-08-20       Impact factor: 4.064

6.  Hereditary hemochromatosis in the post-HFE era.

Authors:  John K Olynyk; Debbie Trinder; Grant A Ramm; Robert S Britton; Bruce R Bacon
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

7.  Cell-type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chronic HBV infected patients.

Authors:  Yanling Zhu; Bo Qin; Chunyan Xiao; Xi Lu; Limin Chen
Journal:  Dig Dis Sci       Date:  2012-05-15       Impact factor: 3.199

8.  Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C.

Authors:  Hironori Mitsuyoshi; Kohichiroh Yasui; Kanji Yamaguchi; Masahito Minami; Takeshi Okanoue; Yoshito Itoh
Journal:  Int J Hepatol       Date:  2013-04-04

9.  The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients.

Authors:  Glenn S Gerhard; Ravi Chokshi; Christopher D Still; Peter Benotti; G Craig Wood; Mollie Freedman-Weiss; Cody Rider; Anthony T Petrick
Journal:  Patient Saf Surg       Date:  2011-01-10

10.  Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Authors:  Bruce R Bacon; Paul C Adams; Kris V Kowdley; Lawrie W Powell; Anthony S Tavill
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.